262 related articles for article (PubMed ID: 22426690)
1. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
Du N; Feng J; Hu LJ; Sun X; Sun HB; Zhao Y; Yang YP; Ren H
Oncol Rep; 2012 Jun; 27(6):1893-903. PubMed ID: 22426690
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
4. Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer.
Zhao Y; Wang H; Li X; Cao M; Lu H; Meng Q; Pang H; Li H; Nadolny C; Dong X; Cai L
J Cell Physiol; 2014 Nov; 229(11):1855-62. PubMed ID: 24692224
[TBL] [Abstract][Full Text] [Related]
5. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Ager EI; Wen SW; Chan J; Chong WW; Neo JH; Christophi C
BMC Cancer; 2011 Jun; 11():274. PubMed ID: 21703011
[TBL] [Abstract][Full Text] [Related]
6. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
[TBL] [Abstract][Full Text] [Related]
7. Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis.
Mizushima T; Sasaki M; Ando T; Wada T; Tanaka M; Okamoto Y; Ebi M; Hirata Y; Murakami K; Mizoshita T; Shimura T; Kubota E; Ogasawara N; Tanida S; Kataoka H; Kamiya T; Alexander JS; Joh T
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G255-66. PubMed ID: 19940029
[TBL] [Abstract][Full Text] [Related]
8. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells.
Azuma K; Tamura K; Shigenaga A; Wakui H; Masuda S; Tsurumi-Ikeya Y; Tanaka Y; Sakai M; Matsuda M; Hashimoto T; Ishigami T; Lopez-Ilasaca M; Umemura S
Hypertension; 2007 Nov; 50(5):926-32. PubMed ID: 17875818
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II regulates brain (pro)renin receptor expression through activation of cAMP response element-binding protein.
Li W; Liu J; Hammond SL; Tjalkens RB; Saifudeen Z; Feng Y
Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(2):R138-47. PubMed ID: 25994957
[TBL] [Abstract][Full Text] [Related]
10. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
[TBL] [Abstract][Full Text] [Related]
11. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.
Chen X; Meng Q; Zhao Y; Liu M; Li D; Yang Y; Sun L; Sui G; Cai L; Dong X
Cancer Lett; 2013 Jan; 328(2):318-24. PubMed ID: 23092556
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
[TBL] [Abstract][Full Text] [Related]
14. Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.
Hasan AU; Ohmori K; Hashimoto T; Kamitori K; Yamaguchi F; Ishihara Y; Ishihara N; Noma T; Tokuda M; Kohno M
Hypertens Res; 2014 Jul; 37(7):621-8. PubMed ID: 24599011
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.
Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Oya M
Prostate; 2011 Oct; 71(14):1510-7. PubMed ID: 21321983
[TBL] [Abstract][Full Text] [Related]
18. Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-κB and MAPK signaling.
Chen XS; Wang SH; Liu CY; Gao YL; Meng XL; Wei W; Shou ST; Liu YC; Chai YF
Pharmacol Res; 2022 Nov; 185():106473. PubMed ID: 36182039
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
[TBL] [Abstract][Full Text] [Related]
20. Candesartan inhibits LPS-induced expression increase of toll-like receptor 4 and downstream inflammatory factors likely via angiotensin II type 1 receptor independent pathway in human renal tubular epithelial cells.
Zhao LQ; Huang JL; Yu Y; Lu Y; Fu LJ; Wang JL; Wang YD; Yu C
Sheng Li Xue Bao; 2013 Dec; 65(6):623-30. PubMed ID: 24343720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
